• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Six new medicines were recommended by the Danish Medicines Council in June

The Danish Medicines Council launches national basis list for GPs

The Danish Medicines Council and Amgros allow companies more time to propose alternative agreements

The Danish Medicines Council reorganises its secretariat into three centres

The Danish Medicines Council issues ADHD medication guidelines for the primary healthcare sector

Danish Medicines Council decisions from April 2026

Breaking: Denmark speeds up access to PD-(L)1 immunotherapies

Danish Medicines Council declines vamorolone for Duchenne

Janus Laust Thomsen joins Denmark’s medicines council

Danish Medicines Council appraised 84 new medicines in 2025

1 2 Next

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allé 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy